Mumbai has 159 AI companies with $364M raised. One Mumbai-founded diagnostic AI firm is deployed in 20+ countries. Here's the technical breakdown of what production-grade clinical AI from Mumbai's ecosystem actually looks like.
Clinical metrics that matter (not "accuracy")
Sensitivity — % of true positives correctly identified
Specificity — % of true negatives correctly identified
AUC-ROC — discrimination across all decision thresholds
Calibration — are predicted probabilities accurate at real prevalence?
FNR — false negative rate for the clinical stakes involved
Compliance stack
India (clinical use) → CDSCO Medical Device Rules 2017
US market → FDA 510(k) / De Novo clearance
Europe → CE marking under MDR 2017/745
Data handling → HIPAA-aligned, DPDP Act (India)
Integration layer
Imaging AI → DICOM / PACS / HL7 FHIR
Lab AI → LIS integration, instrument API
Clinical AI → EHR/HIS (HL7 v2, FHIR R4)
Top 4 companies (2026)
Prognos Labs — Custom clinical AI + LLMOps + Agentic systems. Compliance-first architecture, TF/PyTorch, cloud-native. 50% workflow cost reductions documented. Full lifecycle partner.
Qure.ai — Deep learning for medical imaging (qXR, qER). $123M raised. WHO-assessed. 10,000+ hospitals, 20+ countries. TB and lung nodule detection at radiologist-level accuracy.
Niramai — Thermal imaging CV for breast cancer. 400k data points/scan. FDA cleared. 200+ hospital deployments.
SigTuple — CV for lab diagnostics. 70%+ microscopy automation. Continuous learning from pathologist-verified labels.
Checklist before adopting clinical AI
[ ] Sensitivity/specificity for your patient population?
[ ] Regulatory clearances confirmed for this use case?
[ ] EHR/PACS/LIS integration verified?
[ ] HIPAA-aligned data governance + audit trail?
[ ] Model drift monitoring + retraining SLA?
[ ] False negative rate acceptable for clinical stakes?
Full evaluation: blog link
What does your clinical AI technical evaluation look like? Comments below.
Top comments (0)